menu
    • menu

    Company profile for Seaport Therapeutics

    NEW Drugs in Dev: 5
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Seaport Therapeutics is a clinical-stage biopharmaceutical entity at the forefront of advancing novel neuropsychiatric medications to address significant unmet patient needs. Our approach involves leveraging our proprietary Glyph technology platform to overcome limitations previously hindering the progress of clinically validated mechanisms. Spearheaded by a seasoned team with a track record of involvement in inventing and dev...
    Seaport Therapeutics is a clinical-stage biopharmaceutical entity at the forefront of advancing novel neuropsychiatric medications to address significant unmet patient needs. Our approach involves leveraging our proprietary Glyph technology platform to overcome limitations previously hindering the progress of clinically validated mechanisms. Spearheaded by a seasoned team with a track record of involvement in inventing and developing KarXT and other neuropsychiatric medicines, we are guided by an extensive network comprising renowned scientists, clinicians, and key opinion leaders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Seaport TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Seaport Boston, MA 02210
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://seaporttx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/seaport-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PureTech's Seaport Publishes GlyphAllo (SPT-300) Data in Science
    PureTech's Seaport Publishes GlyphAllo (SPT-300) Data in Science

    25 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-25/puretech-founded-entity-seaport-therapeutics-announces-publication-in-science-translational-medicine

    PHARMIWEB
    25 Mar 2026
    Share Share
    Seaport Therapeutics Announces Science Translational Medicine
    Seaport Therapeutics Announces Science Translational Medicine

    25 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260325177616/en/Seaport-Therapeutics-Announces-Science-Translational-Medicine-Peer-Reviewed-Publication-Featuring-GlyphAlloTM-SPT-300-as-the-First-Triglyceride-Mimetic-Prodrug-to-Achieve-Therapeutically-Relevant-Drug-Levels-in-Humans

    BUSINESSWIRE
    25 Mar 2026
    Share Share
    Seaport Wins Up to $15M ARPA-H Grant for GlyphCele Therapy
    Seaport Wins Up to $15M ARPA-H Grant for GlyphCele Therapy

    03 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260303881583/en/Seaport-Therapeutics-and-Monash-Institute-of-Pharmaceutical-Sciences-Awarded-up-to-%2415-Million-from-ARPAH-to-Advance-Seaports-GlyphCele-the-First-Oral-Therapeutic-Designed-to-Restore-Gut-Lymphatic-Function

    BUSINESSWIRE
    03 Mar 2026
    Share Share
    Seaport Therapeutics Joins Investor Conferences In Feb. & Mar
    Seaport Therapeutics Joins Investor Conferences In Feb. & Mar

    18 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260218422769/en/Seaport-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences-in-February-and-March

    BUSINESSWIRE
    18 Feb 2026
    Share Share
    Seaport Therapeutics Presents at 44th Annual JP Morgan Conference
    Seaport Therapeutics Presents at 44th Annual JP Morgan Conference

    05 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260105003930/en/Seaport-Therapeutics-to-Present-at-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    05 Jan 2026
    Share Share
    Seaport Therapeutics Validates Glyph for Oral Bioavailability
    Seaport Therapeutics Validates Glyph for Oral Bioavailability

    08 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251208286517/en/Seaport-Therapeutics-Presents-Data-Further-Validating-Glyph-Platforms-Ability-to-Enhance-Oral-Bioavailability-and-Expand-Therapeutic-Reach

    BUSINESSWIRE
    08 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search